GoodRx Inc. (GDRX)
4.63
-0.01 (-0.22%)
At close: Mar 24, 2025, 3:59 PM
4.70
1.47%
After-hours: Mar 24, 2025, 04:44 PM EDT
-0.22% (1D)
| Bid | 4.55 |
| Market Cap | 1.78B |
| Revenue (ttm) | 796.48M |
| Net Income (ttm) | 24.81M |
| EPS (ttm) | 0.04 |
| PE Ratio (ttm) | 115.75 |
| Forward PE | 12.26 |
| Analyst | Buy |
| Ask | 4.7 |
| Volume | 1,203,321 |
| Avg. Volume (20D) | 1,726,366.5 |
| Open | 4.70 |
| Previous Close | 4.64 |
| Day's Range | 4.58 - 4.79 |
| 52-Week Range | 4.09 - 9.26 |
| Beta | 1.26 |
About GDRX
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also...
Sector Healthcare
IPO Date Sep 23, 2020
Employees 738
Stock Exchange NASDAQ
Ticker Symbol GDRX
Website https://www.goodrx.com
Analyst Forecast
According to 9 analyst ratings, the average rating for GDRX stock is "Buy." The 12-month stock price forecast is $8, which is an increase of 72.79% from the latest price.
Stock ForecastsNext Earnings Release
GoodRx Inc. is scheduled to release its earnings on May 8, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+1.84%
GoodRx Holdings shares are trading higher. The com...
Unlock content with
Pro Subscription
4 months ago
-17.51%
GoodRx Holdings shares are trading lower after the company reported worse-than-expected Q3 financial results and issued Q4 and FY24 sales guidance below estimates.
